Why the study?
Current RNA sequencing analyses focus on single-gene outliers linked to cis-acting variants, overlooking causal variants with trans-acting effects on splicing transcriptome wide, such as those impacting spliceosome function.
Population
385 individuals from the GREGoR and UDN consortia
Authors
Loading...
RNA-seq splicing-outlier screening may aid unsolved rare-disease diagnosis; leaves open RNU6ATAC as a Mendelian gene.
Examining RNA-sequencing data for transcriptome-wide signatures of splicing outliers can increase the diagnostic yield for individuals with rare diseases and uncover novel gene-disease associations.
Mendez et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: